Incyte Long Term Debt 2006-2019 | INCY

Incyte long term debt from 2006 to 2019. Long term debt can be defined as the sum of all long term debt fields.
  • Incyte long term debt for the quarter ending March 31, 2019 was $0.018B, a 4.97% increase year-over-year.
  • Incyte long term debt for 2018 was $0.017B, a 4.97% increase from 2017.
  • Incyte long term debt for 2017 was $0.017B, a 97.45% decline from 2016.
  • Incyte long term debt for 2016 was $0.651B, a 5.1% increase from 2015.
Incyte Annual Long Term Debt
(Millions of US $)
2018 $17
2017 $17
2016 $651
2015 $620
2014 $590
2013 $662
2012 $331
2011 $316
2010 $293
2009 $443
2008 $396
2007 $387
2006 $371
2005 $342
Incyte Quarterly Long Term Debt
(Millions of US $)
Q1 2019 $18
Q4 2018 $17
Q3 2018 $17
Q2 2018 $17
Q1 2018 $17
Q4 2017 $17
Q3 2017 $24
Q2 2017 $23
Q1 2017 $42
Q4 2016 $651
Q3 2016 $643
Q2 2016 $635
Q1 2016 $628
Q4 2015 $620
Q3 2015 $624
Q2 2015 $617
Q1 2015 $610
Q4 2014 $590
Q3 2014 $681
Q2 2014 $673
Q1 2014 $665
Q4 2013 $662
Q3 2013 $187
Q2 2013 $224
Q1 2013 $338
Q4 2012 $331
Q3 2012 $325
Q2 2012 $319
Q1 2012 $313
Q4 2011 $316
Q3 2011 $310
Q2 2011 $305
Q1 2011 $299
Q4 2010 $293
Q3 2010 $288
Q2 2010 $283
Q1 2010 $278
Q4 2009 $443
Q3 2009 $626
Q2 2009 $401
Q1 2009 $399
Q4 2008 $396
Q3 2008 $394
Q2 2008 $391
Q1 2008 $389
Q4 2007 $387
Q3 2007 $378
Q2 2007 $375
Q1 2007 $373
Q4 2006 $371
Q3 2006 $369
Q2 2006 $257
Q1 2006 $257
Q4 2005 $342
Q3 2005 $342
Q2 2005 $350
Q1 2005 $379
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $17.530B $1.882B
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. Their first commercial product, Jakafi (ruxolitinib), is approved in the United States for patients with intermediate or high-risk myelofibrosis and for patients with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea. They have a diverse and growing portfolio of product candidates, including both small and large molecules.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $104.470B 11.81
Gilead Sciences (GILD) United States $85.278B 10.35
Celgene (CELG) United States $67.169B 11.38
Illumina (ILMN) United States $45.930B 53.23
Biogen (BIIB) United States $44.025B 8.36
Vertex Pharmaceuticals (VRTX) United States $43.994B 53.18
Regeneron Pharmaceuticals (REGN) United States $34.155B 16.05
Alexion Pharmaceuticals (ALXN) United States $28.512B 16.14
BioMarin Pharmaceutical (BMRN) United States $15.950B 0.00
Exact Sciences (EXAS) United States $12.511B 0.00
Seattle Genetics (SGEN) United States $11.153B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.999B 47.71
Sarepta Therapeutics (SRPT) United States $8.961B 0.00
QIAGEN (QGEN) Netherlands $8.614B 28.30
Bio-Techne Corp (TECH) United States $7.491B 51.11
Alnylam Pharmaceuticals (ALNY) United States $7.344B 0.00
Moderna (MRNA) United States $7.182B 0.00
Bluebird Bio (BLUE) United States $6.772B 0.00
Guardant Health (GH) United States $6.708B 0.00
Exelixis (EXEL) United States $6.144B 15.66
Galapagos (GLPG) Belgium $6.114B 0.00
Array BioPharma (ARRY) United States $6.007B 0.00
BeiGene (BGNE) Cayman Islands $5.905B 0.00
Amarin (AMRN) Ireland $5.693B 0.00
Ascendis Pharma (ASND) Denmark $5.434B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.420B 0.00
Spark Therapeutics (ONCE) United States $4.238B 0.00
Blueprint Medicines (BPMC) United States $4.137B 0.00
Alkermes (ALKS) Ireland $3.758B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.743B 0.00
China Biologic Products (CBPO) China $3.582B 22.75
Allogene Therapeutics (ALLO) United States $3.440B 0.00
Global Blood Therapeutics (GBT) United States $3.380B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.327B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.286B 0.00
Repligen (RGEN) United States $3.252B 81.01
Immunomedics (IMMU) United States $2.835B 0.00
Amicus Therapeutics (FOLD) United States $2.807B 0.00
Mirati Therapeutics (MRTX) United States $2.766B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.745B 0.00
Arena Pharmaceuticals (ARNA) United States $2.648B 5.38
Reata Pharmaceuticals (RETA) United States $2.632B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.616B 0.00
Medicines (MDCO) United States $2.578B 0.00
UniQure (QURE) Netherlands $2.381B 0.00
MyoKardia (MYOK) United States $2.295B 0.00
Halozyme Therapeutics (HALO) United States $2.242B 0.00
Ligand Pharmaceuticals (LGND) United States $2.230B 18.47
Emergent Biosolutions (EBS) United States $2.224B 19.32
Acceleron Pharma (XLRN) United States $2.216B 0.00
Lion Biotechnologies (IOVA) United States $2.131B 0.00
Insmed (INSM) United States $2.045B 0.00
NeoGenomics (NEO) United States $2.029B 132.81
AnaptysBio (ANAB) United States $2.019B 0.00
Genomic Health (GHDX) United States $2.005B 42.58
Denali Therapeutics (DNLI) United States $1.979B 0.00
Akcea Therapeutics (AKCA) United States $1.967B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.958B 0.00
Allakos (ALLK) United States $1.913B 0.00
Myriad Genetics (MYGN) United States $1.797B 17.88
Audentes Therapeutics (BOLD) United States $1.687B 0.00
REGENXBIO (RGNX) United States $1.672B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.659B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.598B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.529B 0.00
Innoviva (INVA) United States $1.469B 4.06
Coherus BioSciences (CHRS) United States $1.412B 0.00
Cambrex (CBM) United States $1.402B 17.73
Gossamer Bio (GOSS) United States $1.355B 0.00
Rubius Therapeutics (RUBY) United States $1.346B 0.00
Alector (ALEC) United States $1.343B 0.00
Aimmune Therapeutics (AIMT) United States $1.266B 0.00
Fate Therapeutics (FATE) United States $1.237B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.209B 0.00
Apellis Pharmaceuticals (APLS) United States $1.208B 0.00
Epizyme (EPZM) United States $1.174B 0.00
Sangamo Therapeutics (SGMO) United States $1.121B 0.00
Eidos Therapeutics (EIDX) United States $1.092B 0.00
Atara Biotherapeutics (ATRA) United States $1.075B 0.00
Editas Medicine (EDIT) United States $1.069B 0.00
Codexis (CDXS) United States $1.045B 0.00
RA PHARMCTL INC (RARX) United States $1.001B 0.00
NGM Biopharmaceuticals (NGM) United States $0.987B 0.00
Athenex (ATNX) United States $0.939B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.924B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.912B 0.00
InflaRx (IFRX) Germany $0.912B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.904B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.895B 0.00
Clovis Oncology (CLVS) United States $0.887B 0.00
Myovant Sciences (MYOV) United Kingdom $0.880B 0.00
WAVE Life Sciences (WVE) Singapore $0.871B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.862B 40.70
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.857B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.854B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.853B 0.00
G1 THERAPEUTICS (GTHX) United States $0.848B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.846B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.843B 0.00
ANI Pharmaceuticals (ANIP) United States $0.825B 14.63
Axsome Therapeutics (AXSM) United States $0.824B 0.00
MeiraGTx Holdings (MGTX) United States $0.812B 0.00
Retrophin (RTRX) United States $0.779B 0.00
Intra-Cellular Therapies (ITCI) United States $0.742B 0.00
Twist Bioscience (TWST) United States $0.729B 0.00
Principia Biopharma (PRNB) United States $0.721B 0.00
Cara Therapeutics (CARA) United States $0.718B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.715B 0.00
Cellectis (CLLS) France $0.715B 0.00
CORTEXYME INC (CRTX) United States $0.712B 0.00
Arvinas (ARVN) United States $0.710B 0.00
Vericel (VCEL) United States $0.692B 0.00
Precision BioSciences (DTIL) United States $0.691B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.685B 0.00
Intellia Therapeutics (NTLA) United States $0.679B 0.00
Zealand Pharma (ZEAL) Denmark $0.664B 7.76
Kura Oncology (KURA) United States $0.654B 0.00
Stemline Therapeutics (STML) United States $0.654B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.629B 0.00
Viking Therapeutics (VKTX) United States $0.615B 0.00
Puma Biotechnology (PBYI) United States $0.597B 0.00
Adverum Biotechnologies (ADVM) United States $0.585B 0.00
Cytokineticsorporated (CYTK) United States $0.580B 0.00
Heska (HSKA) United States $0.580B 59.37
ObsEva SA (OBSV) Switzerland $0.574B 0.00
Magenta Therapeutics (MGTA) United States $0.571B 0.00
Zymeworks (ZYME) Canada $0.566B 0.00
DBV Technologies (DBVT) France $0.550B 0.00
Anika Therapeutics (ANIK) United States $0.541B 18.49
Kaleido Biosciences (KLDO) $0.524B 0.00
Revance Therapeutics (RVNC) United States $0.511B 0.00
Scholar Rock Holding (SRRK) United States $0.510B 0.00
UROGEN PHARMA (URGN) United States $0.502B 0.00
CytomX Therapeutics (CTMX) United States $0.502B 0.00
Synthorx (THOR) United States $0.499B 0.00
MediciNova (MNOV) United States $0.494B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.489B 0.00
Acorda Therapeutics (ACOR) United States $0.489B 8.61
Mesoblast (MESO) Australia $0.478B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.477B 0.00
Replimune (REPL) United States $0.471B 0.00
MILESTONE PHARM (MIST) Canada $0.470B 0.00
Krystal Biotech (KRYS) United States $0.469B 0.00
NEXTCURE INC (NXTC) United States $0.437B 0.00
Sorrento Therapeutics (SRNE) United States $0.429B 0.00
Cyclerion Therapeutics (CYCN) United States $0.415B 0.00
Albireo Pharma (ALBO) United States $0.405B 0.00
Arcus Biosciences (RCUS) United States $0.399B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.394B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.384B 0.00
Agenus (AGEN) United States $0.384B 0.00
BioDelivery Sciences (BDSI) United States $0.384B 0.00
Prothena (PRTA) Ireland $0.378B 0.00
AVROBIO (AVRO) United States $0.376B 0.00
Dynavax Technologies (DVAX) United States $0.376B 0.00
Gritstone Oncology (GRTS) United States $0.374B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
LogicBio Therapeutics (LOGC) United States $0.365B 0.00
UNITY Biotechnology (UBX) $0.363B 0.00
PDL BioPharma (PDLI) United States $0.357B 8.46
Biofrontera AG Sponsored ADR (BFRA) Germany $0.357B 0.00
Kodiak Sciences (KOD) United States $0.352B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.346B 0.00
AC Immune SA (ACIU) Switzerland $0.340B 21.87
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.340B 0.00
Senesco Technologies (ELOX) United States $0.340B 0.00
Kindred Biosciences (KIN) United States $0.332B 0.00
Five Prime Therapeutics (FPRX) United States $0.326B 0.00
AXCELLA HEALTH (AXLA) United States $0.326B 0.00
BeyondSpring (BYSI) United States $0.326B 0.00
XBiotech (XBIT) United States $0.325B 0.00
Kezar Life Sciences (KZR) United States $0.323B 0.00
Abeona Therapeutics (ABEO) United States $0.322B 0.00
Inovio Pharmaceuticals (INO) United States $0.320B 0.00
Cellular Biomedicine (CBMG) United States $0.309B 0.00
Merus (MRUS) Netherlands $0.299B 0.00
Geron (GERN) United States $0.289B 0.00
Kadmon Holdings (KDMN) United States $0.281B 0.00
ResTORbio (TORC) United States $0.273B 0.00
Constellation Pharmaceuticals (CNST) United States $0.272B 0.00
Athersys (ATHX) United States $0.270B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.260B 0.00
Protagonist Therapeutics (PTGX) United States $0.259B 0.00
PHASEBIO PHARMA (PHAS) United States $0.258B 0.00
Aduro Biotech (ADRO) United States $0.256B 0.00
ChromaDex (CDXC) United States $0.255B 0.00
Enochian BioSciences (ENOB) United States $0.250B 0.00
Evelo Biosciences (EVLO) United States $0.245B 0.00
Celcuity (CELC) United States $0.240B 0.00
Sutro Biopharma (STRO) United States $0.238B 0.00
Mersana Therapeutics (MRSN) United States $0.236B 0.00
Urovant Sciences (UROV) United States $0.231B 0.00
Kamada (KMDA) Israel $0.229B 8.88
Syros Pharmaceuticals (SYRS) United States $0.222B 0.00
OvaScience (MLND) United States $0.221B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.220B 0.00
MannKind (MNKD) United States $0.220B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.217B 0.00
Arsanis (XFOR) United States $0.213B 0.00
ADMA Biologics Inc (ADMA) United States $0.213B 0.00
Cerecor (CERC) United States $0.213B 0.00
Avid Bioservices (CDMO) United States $0.213B 0.00
Synlogic (SYBX) United States $0.208B 0.00
Chiasma (CHMA) United States $0.206B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.205B 0.00
Kala Pharmaceuticals (KALA) United States $0.201B 0.00
Spero Therapeutics (SPRO) United States $0.199B 0.00
VBI Vaccines (VBIV) United States $0.199B 0.00
HOOKIPA PHARMA (HOOK) United States $0.198B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.197B 0.00
Solid Biosciences (SLDB) United States $0.195B 0.00
Celyad SA (CYAD) Belgium $0.193B 0.00
Affimed (AFMD) Germany $0.193B 0.00
Neothetics (EVFM) United States $0.191B 0.00
Liquidia Technologies (LQDA) United States $0.177B 0.00
Intec Pharma (NTEC) Israel $0.175B 0.00
Gamida Cell (GMDA) Israel $0.174B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.174B 0.00
Cue Biopharma (CUE) United States $0.173B 0.00
Compugen (CGEN) Israel $0.171B 0.00
APPLIED THERAPT (APLT) United States $0.171B 0.00
BioXcel Therapeutics (BTAI) United States $0.170B 0.00
XOMA (XOMA) United States $0.166B 0.00
Axovant Sciences (AXGT) United Kingdom $0.164B 0.00
Seres Therapeutics (MCRB) United States $0.163B 0.00
Anavex Life Sciences (AVXL) United States $0.162B 0.00
Menlo Therapeutics (MNLO) United States $0.161B 0.00
TREVI THERAPTCS (TRVI) United States $0.160B 0.00
Strongbridge Biopharma (SBBP) United States $0.159B 9.19
Checkpoint Therapeutics (CKPT) United States $0.157B 0.00
SESEN BIO, INC (SESN) United States $0.156B 0.00
Enzo Biochem (ENZ) United States $0.153B 0.00
Eton Pharmaceuticals (ETON) United States $0.147B 0.00
Novavax (NVAX) United States $0.144B 0.00
Provention Bio (PRVB) United States $0.142B 0.00
Mustang Bio (MBIO) United States $0.138B 0.00
OSMOTICA PHARM (OSMT) United States $0.136B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.136B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.127B 0.00
Fortress Biotech (FBIO) United States $0.121B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.118B 0.00
Trevena (TRVN) United States $0.113B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.113B 0.00
Aptinyx (APTX) United States $0.112B 0.00
INmune Bio (INMB) United States $0.111B 0.00
TOCAGEN INC (TOCA) United States $0.109B 0.00
Dyadic (DYAI) United States $0.109B 0.00
Arbutus Biopharma (ABUS) Canada $0.109B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.108B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.107B 0.00
Equillium (EQ) United States $0.105B 0.00
Selecta Biosciences (SELB) United States $0.105B 0.00
NantKwest (NK) United States $0.105B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
Unum Therapeutics (UMRX) United States $0.099B 0.00
Verastem (VSTM) United States $0.098B 0.00
Pluristem Therapeutics (PSTI) Israel $0.097B 0.00
Catalyst Biosciences (CBIO) United States $0.095B 0.00
Allena Pharmaceuticals (ALNA) United States $0.094B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.092B 0.00
Aptose Biosciences (APTO) Canada $0.089B 0.00
VTv Therapeutics (VTVT) United States $0.087B 0.00
Signal Genetics (MGEN) United States $0.086B 0.00
Cohbar (CWBR) United States $0.084B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.084B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.083B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.082B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Cocrystal Pharma (COCP) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.079B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.076B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
NewLink Genetics (NLNK) United States $0.070B 0.00
ARAVIVE, INC (ARAV) United States $0.070B 0.00
Alcobra (ARCT) United States $0.069B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 38.00
Sunesis Pharmaceuticals (SNSS) United States $0.068B 0.00
Orgenesis (ORGS) United States $0.068B 0.00
Prima BioMed (IMMP) Australia $0.067B 0.00
ScPharmaceuticals (SCPH) United States $0.066B 0.00
OVID THERAPEUTC (OVID) United States $0.066B 0.00
Eyenovia (EYEN) United States $0.062B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
Oncobiologics (OTLK) United States $0.062B 0.00
Apricus Biosciences (SEEL) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.056B 0.00
Ophthotech (ISEE) United States $0.055B 0.00
Proteostasis Therapeutics (PTI) United States $0.052B 0.00
AEterna Zentaris (AEZS) United States $0.052B 0.00
Cidara Therapeutics (CDTX) United States $0.051B 0.00
Hoth Therapeutics (HOTH) United States $0.050B 0.00
Moleculin Biotech (MBRX) United States $0.050B 0.00
Curis (CRIS) United States $0.049B 0.00
Zosano Pharma (ZSAN) United States $0.048B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
Evogene (EVGN) Israel $0.045B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Bellerophon Therapeutics (BLPH) United States $0.044B 0.00
Celldex Therapeutics (CLDX) United States $0.044B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.044B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.043B 0.00
Celsion (CLSN) United States $0.043B 0.00
VIVUS (VVUS) United States $0.041B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.040B 0.00
Oncolytics Biotech (ONCY) Canada $0.039B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Edge Therapeutics (PDSB) United States $0.034B 0.00
VistaGen Therapeutics (VTGN) United States $0.034B 0.00
Entera Bio (ENTX) Israel $0.033B 0.00
Bionano Genomics (BNGO) United States $0.033B 0.00
Aptevo Therapeutics (APVO) United States $0.032B 0.00
Aytu Bioscience (AYTU) United States $0.031B 0.00
Caladrius Biosciences (CLBS) United States $0.031B 0.00
Motif Bio Plc (MTFB) United States $0.027B 0.00
Vical (VICL) United States $0.026B 0.00
GENPREX INC (GNPX) United States $0.025B 0.00
Sophiris Bio (SPHS) United States $0.024B 0.00
GTx (GTXI) United States $0.024B 0.00
Adial Pharmaceuticals (ADIL) United States $0.023B 0.00
Bison Capital Acquisition (XYN) China $0.022B 0.00
TRACON Pharmaceuticals (TCON) United States $0.022B 0.00
ATyr Pharma (LIFE) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
CytRx (CYTR) United States $0.019B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
Novelion Therapeutics (NVLN) Canada $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Advaxis (ADXS) United States $0.016B 0.00
Histogenics (HSGX) United States $0.016B 0.00
OncoSec Medical (ONCS) United States $0.016B 0.00
Aileron Therapeutics (ALRN) United States $0.016B 0.00
TrovaGene (TROV) United States $0.015B 0.00
Gemphire Therapeutics (GEMP) United States $0.015B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Galena Biopharma (SLS) United States $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
IMMURON LTD (IMRN) Australia $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
RestorGenex (DFFN) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Vital Therapies (IMUX) United States $0.012B 0.00
Genetic Technologies (GENE) Australia $0.011B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.009B 0.00
Therapix Biosciences (TRPX) Israel $0.009B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Alliqua BioMedical (ADYX) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Cellect Biotechnology (APOP) Israel $0.004B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00